| Tessa Helmle, OTD, OTR/L | |
|
234 N Main St Ste 1a, Gunnison, CO 81230-2437 | |
| (970) 641-2908 | |
| Not Available |
| Full Name | Tessa Helmle |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 234 N Main St Ste 1a, Gunnison, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386253524 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 101680 (Iowa) | Secondary |
| 225X00000X | Occupational Therapist | OT.0006777 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tessa Helmle, OTD, OTR/L 113 Shavano Dr Unit 212c, Gunnison, CO 81230-9391 Ph: (563) 542-8072 | Tessa Helmle, OTD, OTR/L 234 N Main St Ste 1a, Gunnison, CO 81230-2437 Ph: (970) 641-2908 |
News Archive
A team of scientists from France has recently conducted a study to evaluate the sensitivity of the B.1.617 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to antibody-mediated neutralization.
Biogen Idec announced today that the U.S. Food and Drug Administration has extended the initial Prescription Drug User Fee Act date for its review of the Biologics License Application (BLA) for ALPROLIX, the company's investigational long-lasting recombinant factor IX Fc fusion protein candidate for hemophilia B.
Antisense Therapeutics Ltd. (ASX: ANP) has reported further positive results from its collaborative preclinical research studies on the therapeutic potential of ATL1101 in prostate cancer. In experimental models, ATL1101 treatment significantly enhanced the tumor-suppressive effect of the cancer drug Paclitaxel. Paclitaxel is one of a class of drugs known as taxanes.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, today announced the presentation of encouraging initial clinical findings with SAR3419 at the American Society of Hematology (ASH) 51st Annual Meeting and Exposition. Among the findings reported were responses to SAR3419 – administered as a single agent – among patients with B-cell non-Hodgkin's lymphoma that is refractory to treatment with rituximab (Rituxan®).
› Verified 9 days ago
Ms. Jodi L Lindner, OTR/L, CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 711 N Taylor St, Gunnison, CO 81230 Phone: 970-901-5642 | |
Mrs. Nichole A Baker, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 322 N Main St, Gunnison, CO 81230 Phone: 970-641-2001 | |
Mrs. Amelie Kastning Barry, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 322 N Main St, Gunnison, CO 81230 Phone: 970-901-5642 Fax: 970-641-4596 | |
Ms. Carla Fanciullo, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1192 Seneca Dr, Gunnison, CO 81230 Phone: 970-596-4781 | |
Ms. Amy Elizabeth Vanderveer, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 107 E Georgia Ave, Gunnison, CO 81230 Phone: 970-641-2908 |